Peking University
Clinical trials sponsored by Peking University, explained in plain language.
-
Eastern diet takes on hypertension: can a 3-Month meal plan lower blood pressure?
Disease control Not yet recruitingThis trial tests whether a 3-month dietary program, called the Eastern Blood Pressure-Lowering Diet, can improve blood pressure in Chinese adults with hypertension. About 800 participants from workplace canteens will either receive standard hypertension care or also get specially…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
Disease control Not yet recruitingThis trial compares two simple diet strategies — eating only during early hours or cutting staple foods like rice and bread in half — each combined with an app-guided exercise program, against exercise alone. Researchers want to see which approach helps adults with obesity and pr…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Veggies first, carbs last: could meal and exercise order be the key to childhood weight loss?
Disease control Not yet recruitingThis trial tests whether changing the order of exercise (aerobic before anaerobic, or vice versa) and the order of eating (vegetables and protein first, carbohydrates last) helps overweight children and teens lose weight and improve health. Over 28 days at a weight loss camp, par…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug duo takes aim at hard-to-treat stomach cancer with liver metastases
Disease control Not yet recruitingThis phase 3 trial compares a new drug called Retlirafusp alfa plus chemotherapy against standard immunotherapy plus chemotherapy for people with advanced stomach or gastroesophageal junction cancer that has spread to the liver and has not been treated before. The study aims to s…
Phase: PHASE3 • Sponsor: Peking University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New cancer drug SIG001 enters first human tests
Disease control Not yet recruitingThis early-stage trial tests a new biologic drug, SIG001, in 66 people with advanced solid tumors. The main goals are to check safety, find the right dose, and see how the drug behaves in the body. Participants receive SIG001 intravenously every two weeks and are monitored for si…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo therapy targets Stomach-Lining cancer in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug combination (PX plus nab-paclitaxel) given directly into the abdomen for people with a type of advanced cancer that has spread to the lining of the belly. The main goal is to find a safe dose and check for side effects. About 22 adults with…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
AI-Powered diet coach aims to revolutionize diabetes care in china
Disease control Not yet recruitingThis study tests a new approach to managing type 2 diabetes that combines an AI smartphone app with support from family doctors. About 1200 adults in China will use the app to track their meals and get personalized feedback, while also receiving regular check-ins from their docto…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
School-Based digital tool aims to curb childhood obesity in beijing
Prevention Not yet recruitingThis study tests a school-based weight management program using a WeChat digital platform to help children in Fangshan District, Beijing, avoid excessive weight gain. About 1,400 children in grades 2 and 3 will either receive the program (health classes, daily physical activity, …
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Smartphone app aims to stop pregnancy diabetes before it starts
Prevention Not yet recruitingThis study tests a digital health program that uses patient data to identify pregnant women at high risk for gestational diabetes. High-risk participants will receive online education, lifestyle coaching, and self-management tools to prevent the condition. The goal is to reduce d…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Salt switch could shield Moms-to-Be from dangerous pregnancy complication
Prevention Not yet recruitingThis study tests whether using a low-sodium salt substitute instead of regular salt can lower blood pressure and prevent pregnancy-related high blood pressure disorders in women at high risk. About 3,200 pregnant women in China will be randomly assigned to use either the salt sub…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated Jun 27, 2026 08:07 UTC
-
Botox battle: which injection site lifts drooping mouth corners best?
Symptom relief Not yet recruitingThis study compares two injection sites for Botox to treat drooping mouth corners, a common sign of aging. 266 adults aged 18-60 will receive a single injection either in the upper or lower part of a specific mouth muscle. The goal is to see which spot works better and safer, and…
Phase: PHASE4 • Sponsor: Peking University • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
AI writing coach aims to ease teen grief in landmark trial
Symptom relief Not yet recruitingThis study tests whether an AI-assisted writing program can help Chinese teenagers (ages 10-19) who are struggling with prolonged grief after losing a loved one. Participants will complete three guided writing sessions over six days, with some receiving personalized AI feedback. …
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New study aims to personalize depression treatment with escitalopram
Symptom relief Not yet recruitingThis study looks at how well and safely the antidepressant escitalopram works in people experiencing their first episode of major depression who have never taken medication for it. Two hundred adults aged 18 to 65 will take escitalopram for 8 weeks, and researchers will track the…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can computer brain games boost memory in seniors? new study seeks answers
Symptom relief Not yet recruitingThis study will test whether different amounts of computerized brain training can improve thinking and memory in older adults with mild cognitive impairment. About 234 people aged 60 and older will be assigned to one of several training schedules over 12 weeks. Researchers will t…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Salt showdown: new study puts blood pressure to the test
Knowledge-focused Not yet recruitingThis study looks at how people with slightly high blood pressure react to salt. Participants will eat both high-salt and low-salt meals to see if their blood pressure changes. The goal is to find out who is salt-sensitive and who is not. No new treatments are tested—just careful …
Phase: NA • Sponsor: Peking University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC